medigraphic.com
ISSN 1561-2929 (Print)

2015, Number 2

Next >>

RCAN 2015; 25 (2)

Editorial

Santana PS

Language: Spanish
References: 47
Page: 234-242
PDF size: 208.39 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Hercberg S, Preziosi P, Galan P. Iron deficiency in Europe. Public Health Nutrition 2001; 4(2b):537-45.

  2. Pasricha SR, Drakesmith H, Black J, Hipgrave D, Biggs BA. Control of iron deficiency anemia in low-and middle income countries. Blood 2013;121:2607-17.

  3. Jordão RE, Bernardi JLD, Barros Filho ADA. Prevalência de anemia ferropriva no Brasil: Uma revisão sistemática. Rev Paul Pediatr 2009;27:90-8.

  4. Pérez R. The public health sector and nutrition in Cuba. MEDICC Review 2009;11:6-8.

  5. Gigato Mesa E. Intervención alimentaria y nutrimental en la anemia ferripriva en los niños desnutridos. RCAN Rev Cubana Aliment Nutr 2014;24:106-20.

  6. Padrón M. Plan integral para la prevención y el control de la anemia por deficiencia de hierro en Cuba. Ministerio de Salud Pública. La Habana: 2009.

  7. Olude O. Impact of nutrition education and counseling on anemia prevalence and iron status in women of reproductive age: a systematic review. Doctoral dissertation. Emory University: 2005. Disponible en: https://etd.library.emory.edu/file/view/pid/emory:93hnp/olude_dissertation.pdf. Fecha de última visita: 10 de Diciembre del 2015.

  8. Lipman TO. Grains or veins: Is enteral nutrition really better than parenteral nutrition? A look at the evidence. JPEN J Parenter Enteral Nutr 1998;22:167-82.

  9. Morris SE. Development of oral-motor skills in the neurologically impaired child receiving non-oral feedings. Dysphagia 1989;3:135-54.

  10. Sanders KD, Cox K, Cannon R, Blanchard D, Pitcher J, Papathakis P; et al. Growth response to enteral feeding by children with cerebral palsy. JPEN J Parenter Enteral Nutr 1990;14: 23-6.

  11. Spetter MS, Mars M, Viergever MA, de Graaf C, Smeets PA. Taste matters- Effects of bypassing oral stimulation on hormone and appetite responses. Physiol Behav 2014;137:9-17.

  12. Santana Porbén S, Ochoa C, Muñoz Muñoz G. Hambre, apetito, saciedad, obesidad y síndrome metabólico. En: Síndrome metabólico y enfermedad cardiovascular [Editores: González Chávez A, Lavalle González FJ, Ríos González JJ]. Quinta Edición: Aplicaciones a la práctica clínica. Editores InterSistemas. Ciudad México: 2015. pp 27-44.

  13. Plasencia Concepción D. La formación de recursos humanos en Alimentación y Nutrición. En: Conferencias magistrales. Actas del III Congreso de Nutrición Clínica. La Habana: Junio 21 – 23, 2005. RCAN Rev Cubana Aliment Nutr 2007;17(1 Supl);S20-S28.

  14. Puig Peña Y, Leyva Castillo V, Apórtela López N, Campos González N, Frerer Márquez Y, Soto Rodríguez P. Serogrupos y resistencia antimicrobiana de cepas de Eschericha coli aisladas en alimentos procedentes de brotes de enfermedades diarreicas. RCAN Rev Cubana Aliment Nutr 2014:24:161-71.

  15. Spellberg B, Guidos R, Gilbert D, Bradley J, Boucher HW, Scheld WM; et al; for the Infectious Diseases Society of America. The epidemic of antibiotic-resistant infections: A call to action for the medical community from the Infectious Diseases Society of America. Clinical Infectious Diseases 2008;46:155-64.

  16. Eiland EH, Gatlin D. Forecast of antibiotic development in an era of increasing bacterial resistance. J Pharmacy Practice 2008;21:313-8.

  17. Cartelle Gestal M, Villacís JE, Alulema MJ, Chico P. De la granja a la mesa. Implicaciones del uso de antibióticos en la crianza de animales para la resistencia microbiana y la salud. RCAN Rev Cubana Aliment Nutr 2014;24:129-39.

  18. Miller MB, Bassler BL. Quorum sensing in bacteria. Annu Rev Microbiol 2001;55:165-99.

  19. Barrera Cruz A, Rodríguez González A, Molina Ayala MA. Escenario actual de la obesidad en México. Rev Med Inst Mex Seguro Soc 2013;51:292-9.

  20. Anukam KC, Reid G. Probiotics: 100 years (1907-2007) after Elie Metchnikoff’s observation. Communicat Current Res Educational Topics Trends Applied Microbiol 2007; 1:466-74.

  21. Isolauri E, Sütas Y, Kankaanpää P, Arvilommi H, Salminen S. Probiotics: Effects on immunity. Am J Clin Nutr 2001;73:S444-S450.

  22. Bologa RM, Levine DM, Parker TS, Cheigh JS, Serur D, Stenzel KH, Rubin AL. Interleukin- 6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis 1998;32:107-14.

  23. Jeschke MG, Chinkes DL, Finnerty CC. Pathophysiologic response to severe burn injury. Ann Surg 2008;248:387-401.

  24. Hart DW, Wolf SE, Mlcak R, Chinkes DL, Ramzy PI, Obeng MK; et al. Persistence of muscle catabolism after severe burn. Surgery 2000;128:312-9.

  25. Allred CRG, Voss AC, Finn SC, McCamish MA. Malnutrition and clinical outcomes: The case for medical nutrition therapy. J Am Diet Assoc 1996;96:361-9.

  26. Machín MP, Sueiro ML, de la Cruz A, Boffill MA, Morón F, Méndez OR, Cárdenas J. Uso tradicional de plantas medicinales con acción diurética en el Municipio de Quemado de Güines, Cuba. Rev Biol Trop 2011;59:1859-67.

  27. Anónimo. Alimentación y nutrición en la enfermedad renal crónica. RCAN Rev Cubana Aliment Nutr 2014;24(2 Supl 1):S1-S186.

  28. Wöhler F. Ueber künstliche bildung des harnstoffs. Annalen der Physik und Chemie 1828;88 (2):253-6.

  29. Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: Evidence on causality from a meta-analysis. BMJ 2002;325:1202.

  30. Nevado Jr JB, Imasa MS. Homocysteine predicts adverse clinical outcomes in unstable angina and non-ST elevation myocardial infarction: Implications from the folate intervention in non-ST elevation myocardial infarction and unstable angina study. Coron Artery Dis 2008; 19:153-61.

  31. Hajer GR, Van Der Graaf Y, Olijhoek JK, Verhaar MC, Visseren FL. Levels of homocysteine are increased in metabolic syndrome patients but are not associated with an increased cardiovascular risk, in contrast to patients without the metabolic syndrome. Heart 2007;93: 216-24.

  32. Shabir GA. A practical approach to validation of HPLC methods under current good manufacturing practices. J Validation Technol 2004;10:210-8.

  33. Gil del Valle L, Milian LDLC, Toledo A, Vilaró N, Tápanes R, Otero MA. Altered redox status in patients with diabetes mellitus type I. Pharmacol Res 2005;51:375-80.

  34. Ruiz DH, Cuba SSCVC. Sistema antioxidante enzimático e indicadores de daño oxidativo en pacientes diabéticos tipo 2. Rev Chilena Endocrinol Diabetes 2014;3:0-0. Disponible en: http://www.revistasoched.cl/3_2014/4-heredia.html. Fecha de última visita: 29 de Diciembre del 2015.

  35. Zorrilla AE. El envejecimiento y el estrés oxidativo. Rev Cubana Invest Biomed 2002; 21:178-85.

  36. Gutteridge J. Ageing and free radicals. Med Lab Sci 1992;49:313-8.

  37. Lee J, Koo N, Min DB. Reactive oxygen species, aging, and antioxidative nutraceuticals. Comprehensive Rev Food Sci Food Safety 2004;3:21-33.

  38. Temple NJ. Antioxidants and disease: More questions than answers. Nutrition Research 2000;20:449-59.

  39. Salabarría González JR, Santana Porbén S, Liriano Ricabal MR. Excreción urinaria de una sustancia predicha del índice sustancia-creatinina. Rev Latinoam Patol Clín Med Lab 2015; 62:120-7.

  40. Martinuzzi ALN, Alcántara S, Corbal A, Di Leo ME, Guillot A, Palaoro A; et al. Nitrógeno ureico urinario como indicador del metabolismo proteico en el paciente crítico. RCAN Rev Cubana Aliment Nutr 2011;21:224-35.

  41. Konstantinides FN. Nitrogen balance studies in clinical nutrition. Nutr Clin Pract 1992;7: 231-8.

  42. Caleffi A, Manoni F, Alessio MG, Ottomano C, Lippi G. Quality in extra-analytical phases of urinanalysis. Biochem Med [Zagreb] 2010; 20:179-83.

  43. Tormo C, Lumbreras B, Santos A, Romero L, Conca M. Strategies for improving the collection of 24-hour urine for analysis in the clinical laboratory: Redesigned instructions, opinion surveys, and application of reference change value to micturition. Arch Pathol Lab Med 2009;133:1954-60.

  44. Price CP, Newall RG, Boyd JC. Use of protein:creatinine ratio measurements on random urine samples for prediction of significant proteinuria: A systematic review. Clin Chem 2005; 51:1577-86.

  45. Pathania M, Rathaur VK, Yadav N, Jayara A, Chaturvedi A. Quantitative micro-albuminuria assessment from “random voided urinary albumin: creatinine ratio” versus “24 hours urinary albumin concentration” for screening of diabetic nephropathy. J Clin Diagn Res 2013;7: 2828-31.

  46. Flury S, Trachsler J, Schwarz A, Ambühl PM. Quantification of excretory renal function and urinary protein excretion by determination of body cell mass using bioimpedance analysis. BMC Nephrology 2015;16:174-86. DOI: 10.1186/s12882-015-0171-9.

  47. Tanaka T, Okamura T, Miura K, Kadowaki T, Ueshima H, Nakagawa H; et al. A simple method to estimate populational 24-h urinary sodium and potassium excretion using a casual urine specimen. J Human Hypertens 2002;16:97-103.




2020     |     www.medigraphic.com